Access brought to you by: LOCKSS

Endocrinology

Novel Targets in Insulin Resistance and Type 2 Diabetes
Neurocognitive Decline Unrelated to Mild Cognitive Impairment in Type 1 Diabetes
Cellular-Based Strategies, Closed-Loop Algorithms Are Latest Developments in Therapy for Type 1 Diabetes
Metformin/Pioglitazone/Exenatide Triple Therapy Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed Type 2 Diabetes
Carbohydrate Counting Does Not Improve Glycemic Control in Type 1 Diabetes Patients
Insulin Dose Not Linked to Cardiovascular Mortality in the ACCORD Trial
Lifestyle Intervention is Beneficial in Pregnant Women at Risk for Gestational Diabetes
Canagliflozin Reduces HbA1C in Patients with Stage 3 CKD, with the Change Greater in Patients with Higher eGFR
Education Improves Hypoglycemia Awareness Regardless of Technology Used for Insulin Delivery
Cardiovascular Safety of Linagliptin in Patients with Type 2 Diabetes

Pages